Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

OXFORD UNIV PRESS INC

1. Association of Community Cancer Centers
2. America's Health Insurance Plans
3. AIM Specialty Health
4. American College of Chest Physicians
5. American Society of Clinical Oncology
6. Defined Health
7. Express Scripts
8. Genentech
9. Goldman Sachs
10. McKinsey and Company
11. MPM Capital
12. National Comprehensive Cancer Network
13. Biotechnology Industry Organization
14. American Journal of Managed Care
15. Boston Consulting Group
16. Foundation Medicine
17. Anthem Inc.
18. Novartis
19. Excellus Health Plan
20. National Institutes of Health [P30 CA 008748]
21. Kaiser Foundation Health Plan
22. Laura and John Arnold Foundation
23. Taiho Pharmaceuticals
24. Barclays